Deep-Dive Due Diligence AI Generated Report on CNS Pharmaceuticals, Inc. Common Stock (CNSP)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.


CNSP_OUT_1 [2025-03-19 11:43:37 -0400] 2137 Bytes | 570 tokens | Cum: 570 tkns (7.12% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at CNS Pharmaceuticals (CNSP) which is at 4.28 up from 3.55. So, I pulled together a bunch of data for you to look over real fast. It's still early, 11:43:35 AM on Wednesday March 19, 2025 ET (UTC-0400). So, what's the verdict? You're the expert!

Here's the first list of news for CNS Pharmaceuticals:

C1 - Feb-26-25 09:05AM - CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
C2 - Feb-20-25 09:00AM - CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
C3 - Feb-19-25 09:00AM - CNS Pharmaceuticals, Inc. Participates in the Virtual Investor 'Top 5 for '25' On-Demand Conference
C4 - Feb-19-25 09:00AM 08:30AM - CNS Pharmaceuticals Announces Reverse Stock Split
C5 - Feb-18-25 09:00AM - CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit
C6 - Feb-10-25 08:00AM - CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
C7 - Dec-05-24 09:10AM - CNS Pharmaceuticals to Host Virtual Analyst and Investor Day on December 11, 2024
C8 - Dec-05-24 09:10AM 09:10AM - CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024

ONLY 3 RULES for AI:
==============
1) This is a document retrieval system. You are the analyst-investigator.
2) You can request items from any list to get more details about CNS Pharmaceuticals (CNSP)
3) AFTER requesting and reading News and SEC filings you'll get tokens to write a summary, set a score and high price target, and finally take an exit quiz.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.

Thank you for your analysis of CNS Pharmaceuticals.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!

Please request a document, read, summarize and score. Say something like "C1".

CNSP_IN_2 [2025-03-19 11:43:37 -0400] 2 Bytes | 2 tokens | Cum: 572 tkns (7.15% of 8k)
==========================================================================

C1

CNSP_OUT_3 [2025-03-19 11:43:42 -0400] 376 Bytes | 107 tokens | Cum: 679 tkns (8.49% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing**
Date: Feb-26-25 09:05AM
Source: (ACCESSWIRE)
URL: https://www.accesswire.com/viewarticle.aspx?id=991839

Error fetching article: 403 Client Error: Forbidden for url: https://www.accesswire.com/viewarticle.aspx?id=991839

-- More? (MOR) or Next section? (NEX)

CNSP_IN_4 [2025-03-19 11:43:42 -0400] 389 Bytes | 69 tokens | Cum: 748 tkns (9.35% of 8k)
==========================================================================

As a financial analyst, it's unfortunate that I can't provide a detailed analysis on this update as the source article is not accessible. However, the title suggests that CNS Pharmaceuticals has provided new information on their current financial standing and their status on the NASDAQ. I would recommend trying to access the article from a different source for more detailed information.

CNSP_OUT_5 [2025-03-19 11:43:43 -0400] 981 Bytes | 267 tokens | Cum: 1015 tkns (12.69% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-19T10:08:09Z - Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABS...
A2 - 2025-02-26T14:49:29Z - CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing...
A3 - 2025-02-26T14:12:51Z - CNS Pharmaceuticals secures NASDAQ listing and funding into 2026 By Investing.com...
A4 - 2025-02-26T14:14:49Z - CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ L...
A5 - 2025-02-20T14:37:38Z - CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CNSP_IN_6 [2025-03-19 11:43:43 -0400] 2 Bytes | 2 tokens | Cum: 1017 tkns (12.71% of 8k)
==========================================================================

A1

CNSP_OUT_7 [2025-03-19 11:43:45 -0400] 967 Bytes | 279 tokens | Cum: 1296 tkns (16.20% of 8k)
==========================================================================

Showing A1 (chunk 1 of 5): A1:
**Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABSI), Aterian (NASDAQ:ATER)**Date: 2025-03-19Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/25/03/44393362/why-stoneco-shares-are-trading-higher-by-8-here-are-20-stocks-moving-premarketShares of StoneCo Ltd. STNE rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter earnings and sales results.

StoneCo shares jumped 8% to $10.64 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

Leishen Energy Holding Co., Ltd. LSE gained 90% to $14.31 in pre-market trading after jumping over 46% on Tuesday. The company recently reported FY24 financial results. Virpax Pharmaceuticals, Inc. VRPX rose 35.4% to $0.1760 in pre-market trading after the compan

-- More? (MOR) or Next section? (NEX)

CNSP_IN_8 [2025-03-19 11:43:45 -0400] 3 Bytes | 2 tokens | Cum: 1298 tkns (16.23% of 8k)
==========================================================================

NEX

CNSP_OUT_9 [2025-03-19 11:43:46 -0400] 1048 Bytes | 309 tokens | Cum: 1607 tkns (20.09% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-09-03T12:00:00Z - IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
B2 - 2024-02-09T13:35:36Z - Top 5 Health Care Stocks That Are Preparing To Pump In February
B3 - 2024-01-30T18:18:27Z - Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B4 - 2024-01-30T12:52:14Z - Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
B5 - 2023-10-16T17:09:53Z - Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B6 - 2023-08-21T18:36:57Z - Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CNSP_IN_10 [2025-03-19 11:43:46 -0400] 2 Bytes | 2 tokens | Cum: 1609 tkns (20.11% of 8k)
==========================================================================

B3

CNSP_OUT_11 [2025-03-19 11:43:47 -0400] 969 Bytes | 262 tokens | Cum: 1871 tkns (23.39% of 8k)
==========================================================================

Showing B3 (chunk 1 of 3): B3:
**Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/01/36851751/why-ups-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-tuesdays-mid-day-sessionShares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales guidance below estimates.
UPS reported a fourth-quarter fiscal 2023 revenue decline of 7.8% year-over-year to $24.92 billion, missing the consensus of $25.43 billion. Adjusted EPS was $2.47, down from $3.62 in Q4 2022, in line with the consensus.
United Parcel Service shares dipped 8.3% to $145.04 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers

Agape ATP Corporation (NASDAQ: ATPC) share

-- More? (MOR) or Next section? (NEX)

CNSP_IN_12 [2025-03-19 11:43:48 -0400] 3 Bytes | 2 tokens | Cum: 1873 tkns (23.41% of 8k)
==========================================================================

MOR

CNSP_OUT_13 [2025-03-19 11:43:49 -0400] 967 Bytes | 263 tokens | Cum: 2136 tkns (26.70% of 8k)
==========================================================================

Showing B3 (chunk 2 of 3): s jumped 79% to $0.9120.
Pixelworks, Inc. (NASDAQ: PXLW) rose 56.8% to $2.3209 after the company entered into a multi-year agreement with Walt Disney Studios.
Agrify Corporation (NASDAQ: AGFY) surged 50.7% to $0.9120 after a 13D filing showed I-Tseng Jenny Chan reported a 49.99% stake in the company.
Rail Vision Ltd. (NASDAQ: RVSN) gained 38.8% to $20.38 after the company announced its next generation AI-based computer to be incorporated in its Main Line and Switch Yard systems.
Inspire Veterinary Partners, Inc. (NASDAQ: IVP) climbed 38% to $0.2359 after falling around 24% on Monday. Inspire Veterinary Partners recently filed a prospectus related to up to a $5 million public offering.
Sanmina Corporation (NASDAQ: SANM) shares climbed 36.7% to $69.21 after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates.
Selina

-- More? (MOR) or Next section? (NEX)

CNSP_IN_14 [2025-03-19 11:43:49 -0400] 13 Bytes | 3 tokens | Cum: 2139 tkns (26.74% of 8k)
==========================================================================

Next section.

CNSP_OUT_15 [2025-03-19 11:43:50 -0400] 1146 Bytes | 319 tokens | Cum: 2458 tkns (30.73% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S1 - 2025-01-03 8-K Item 7.01 Regulation FD Disclosure

On January 3, 2025, CNS Pharmaceuticals, Inc. (the Company) posted the investor presentation set forth in Exhibit 99.1 on its website.

The information contained in Item 7.01 of this Curr Report on Form 8-K is being furnished and shall not ...

S2 - 2024-12-11 8-K Item 7.01 Regulation FD Disclosure

On December 11, 2024, CNS Pharmaceuticals, Inc. (the Company), will hold a virtual analyst and investor day meeting at which the presentation set forth in Exhibit 99.1 will be reviewed.

The information contained in Item 7.01 of this Curr R...

S3 - 2024-11-14 10-Q PART I - FIN INFO

ITEM 1. FIN STATEMENTS

CNS Pharmaceuticals, Inc.

Balance Sheets

(Unaudited)

September 30, 2024 December 31, 2023 Assets Curr Assets: Cash and cash equiv $ 6,973,124 $ 548,721 Deferred offering costs 26,932 202,859 Prepaid exp...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

CNSP_IN_16 [2025-03-19 11:43:50 -0400] 2 Bytes | 2 tokens | Cum: 2460 tkns (30.75% of 8k)
==========================================================================

S1

CNSP_OUT_17 [2025-03-19 11:43:56 -0400] 661 Bytes | 158 tokens | Cum: 2618 tkns (32.73% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 7.01 Regulation FD Disclosure

On January 3, 2025, CNS Pharmaceuticals, Inc. (the Company) posted the investor presentation set forth in Exhibit 99.1 on its website.

The information contained in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be filed for the purpose of the Securities Exchange Act of 1934, as amended (Exchange Act), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (Securities Act), unless specifically identified therein as being incorporated by reference....

-- More? (MOR) or Next section? (NEX)

CNSP_IN_18 [2025-03-19 11:43:56 -0400] 438 Bytes | 93 tokens | Cum: 2711 tkns (33.89% of 8k)
==========================================================================

This information pertains to CNS Pharmaceuticals, Inc. and their recent investor presentation that was posted on their website on January 3, 2025. The company has made it clear that the information provided in Item 7.01 of their Current Report on Form 8-K is for informational purposes only and is not to be filed for the purpose of the Securities Exchange Act of 1934, or the Securities Act of 1933, unless specifically stated otherwise.

CNSP_OUT_19 [2025-03-19 11:44:09 -0400] 3164 Bytes | 762 tokens | Cum: 3473 tkns (43.41% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+
| Prev Close: 3.55 | RSI (14): 60.25 | Perf Quarter: -16.42% | Insider Trans: 0.00% | Sales Q/Q: - | ROE: -2116.75% |
+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+
| Target Price: 112.50 | ATR (14): 0.61 | Index: - | Option/Short: No / No | Sales past 5Y: 0.00% | ROI: -508.80% |
+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+
| Price: 4.30 | SMA20: 52.89% | Market Cap: 11.79M | Short Float: 9.87% | Income: -17.06M | Sales Surprise: - |
+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+
| Change: 21.13% | SMA50: -0.18% | Shs Outstand: 2.74M | Short Ratio: 0.42 | Employees: 5 | EPS Surprise: -150.00% |
+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+
| Volume: 389,665 | SMA200: -85.48% | Shs Float: 2.72M | Short Interest: 0.27M | Debt/Eq: 0.01 | P/E: - |
+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+
| Avg Volume: 634.06K | Perf Week: 69.96% | Inst Own: 1.80% | Beta: 0.62 | Sales Y/Y TTM: - | Earnings: Nov 15 BMO |
+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+
| Rel Volume: 1.82 | Perf Month: -39.65% | Insider Own: 0.80% | Sales: 0.00M | Profit Margin: - | |
+----------------------+---------------------+-----------------------+-----------------------+----------------------+------------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Now we've reached the end of the analysis.
You are now allotted tokens to make a final analysis summary.
Please don't use tokens to explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you think there's a 90% likelihood of an upward moves, say: MARKET_SCORE[90]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.

After you have completed that, please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]

CNSP_IN_20 [2025-03-19 11:44:09 -0400] 1231 Bytes | 282 tokens | Cum: 3755 tkns (46.94% of 8k)
==========================================================================

The metrics present a mixed picture for this stock. The positive indicators include a significant price change of 21.13%, a RSI of 60.25 which implies that the stock is not overbought, and a relative volume of 1.82 which indicates higher trading activity. This could potentially be a sign of increasing investor interest. The weekly performance also shows a large increase of 69.96%.

However, there are also several areas of concern. The stock has had a sharp decline over the last quarter (-16.42%) and month(-39.65%), and the 200-day simple moving average is down 85.48%, which may indicate a longer-term downtrend. Also, the Return on Equity (ROE) and Return on Investment (ROI) are both heavily negative, suggesting the company is not generating a positive return.

The company's sales for the past five years and the last quarter are not growing. Also, the company has a negative income of -17.06M and a negative EPS surprise of -150.00%, which could be a cause for concern. The debt to equity ratio is low, which is a good sign, but given the other financial indicators, it appears this company may be struggling.

MARKET_SCORE[45]
PRICE_TARGET[$4.75]

AI_RPT_HEADLINE: "Stock Shows Signs of Life Despite Negative Returns"

CNSP_OUT_21 [2025-03-19 11:44:11 -0400] 561 Bytes | 131 tokens | Cum: 3886 tkns (48.58% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More financial metrics
-> X3 <- More SEC filings & insider data
-> X4 <- Broader sector & market news
-> X5 <- General market sentiment & AI confidence levels
-> X6 <- AI's past analysis on similar companies
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

CNSP_IN_22 [2025-03-19 11:44:11 -0400] 31 Bytes | 7 tokens | Cum: 3893 tkns (48.66% of 8k)
==========================================================================

-> X2 <- More financial metrics

CNSP_IN_23 [2025-03-19 11:44:11 -0400] 126 Bytes | 29 tokens | Cum: 3922 tkns (49.02% of 8k)
==========================================================================

====================================
[2025-03-19 08:44:11] # Analysis Completed
Elapsed Time: 36.28 seconds




Scroll to Top